ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 426 filers reported holding ENCOMPASS HEALTH CORP in Q1 2019. The put-call ratio across all filers is 2.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,623,000 | -3.5% | 61,602 | +0.3% | 0.57% | -3.6% |
| Q2 2021 | $4,793,000 | -6.5% | 61,423 | -1.8% | 0.59% | -9.0% |
| Q1 2021 | $5,124,000 | -9.1% | 62,558 | -8.2% | 0.65% | -13.1% |
| Q4 2020 | $5,636,000 | +21.6% | 68,164 | -4.5% | 0.74% | +16.8% |
| Q3 2020 | $4,636,000 | +2.9% | 71,351 | -1.9% | 0.64% | -5.2% |
| Q2 2020 | $4,506,000 | -5.6% | 72,762 | -2.4% | 0.67% | -22.0% |
| Q1 2020 | $4,774,000 | -13.2% | 74,553 | -6.1% | 0.86% | +20.1% |
| Q4 2019 | $5,498,000 | +5.4% | 79,366 | -3.7% | 0.72% | +4.7% |
| Q3 2019 | $5,218,000 | -5.2% | 82,457 | -5.1% | 0.68% | -3.7% |
| Q2 2019 | $5,506,000 | +1.8% | 86,893 | -6.1% | 0.71% | -2.3% |
| Q1 2019 | $5,407,000 | -8.4% | 92,583 | -3.2% | 0.73% | -14.1% |
| Q4 2018 | $5,902,000 | -29.4% | 95,663 | -10.8% | 0.85% | -7.1% |
| Q3 2018 | $8,359,000 | +13.1% | 107,236 | -1.8% | 0.91% | +11.9% |
| Q2 2018 | $7,394,000 | – | 109,190 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |